We are a biotech spin-off developing an innovative cell therapeutic platform to create next generation cell therapies in oncology. Our products - STAb Therapeutics - have been developed based on solid discoveries from our team of scientific founders at the Hospital 12 de Octubre in Madrid. We are harnessing cell engineering techniques to develop a new wave of cell therapies capable of efficiently redirecting the immune system with our STAb Therapeutics. Our technological approach involves a T cell redirecting strategy that combines principles of adoptive cell therapy and bispecific antibodies. This approach is based on the in vivo production of T cell-engagers (TCE) by engineered cells, which results in effective serum concentrations of TCE, expansion and persistence of adoptively transferred STAb – T cells, and polyclonal recruitment of both modified and unmodified bystander T cells present at the tumor microenvironment. We have validated the therapeutic potential of STAb -T cells in B-cell and T cell hematological malignancies, and we aim to develop this platform to provide new therapeutic solutions to both hematological and solid tumors.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Calle De Ferraz, 78, Madrid,community Of Madrid 28008,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://stabtherapeutics.com/
- HQ
- Madrid, Community of Madrid
Stab Therapeutics Questions
Stab Therapeutics's website is https://stabtherapeutics.com/
Stab Therapeutics's LinkedIn profile is https://es.linkedin.com/company/stabtherapeutics
Stab Therapeutics has
5 employees.
View email and phone details for 5
employees at Stab Therapeutics.
Stab Therapeutics's industry is
Biotechnology Research
Stab Therapeutics's top competitors are
Inhibitec Anticuerpos, S.l.,
Nanological,
Oxolife,
Plusvitech,
A4cell,
Mimo Biosciences,
Duponte Group,
Miramoon Pharma,
Worldpathol,
Bioclonal.
Stab Therapeutics's categories are Biotechnology Research
Stab Therapeutics's founding year is 2022
